The endoscopic prostate enucleation (EEP) is a surgical procedure used to treat benign prostatic hyperplasia (BPH), a condition where the prostate becomes enlarged and blocks urinary flow. The technique involves removing the obstructive inner portion of the prostate, while preserving the outer capsule, which helps maintain the organ’s structure. Methods such as laser enucleation of the prostate (HoLEP or ThuLEP) or bipolar enucleation use energy sources like lasers or bipolar electrical currents to precisely dissect and remove the enlarged tissue. EEP is considered minimally invasive compared to traditional open prostate surgeries, offering significant advantages in terms of reducing blood loss, post-operative pain, and the risk of infections. By directly targeting and removing the tissue causing urinary obstruction, it provides long-term relief from symptoms like frequent urination, weak flow, and incomplete emptying of the bladder.

The precision of the enucleation process allows for a more complete removal of the enlarged prostate tissue, which often results in lower recurrence rates of BPH symptoms compared to other treatments. Patients undergoing EEP generally experience shorter hospital stays, quicker recovery times, and reduced need for catheterization post-surgery. Additionally, EEP is a size independent method and can be safely performed on larger prostates that may not be suitable for other types of surgeries, making it a versatile option. With low complication rates and high success in improving urinary function, EEP is now considered a gold standard for the surgical management of BPH. Its effectiveness and safety make it a preferred option for both patients and healthcare providers dealing with advanced prostate enlargement.